From therapeutic mini proteins to pharma compliance services, international life sciences companies are choosing Leiden as the place to grow. Among them are VRG Therapeutics (Hungary) and CONVAL Group (Turkey) — two companies that recently established operations at the Leiden…
The Biotech Training Facility at Leiden Bio Science Park welcomed the Merck on Tour mobile lab, a travelling showcase of the latest life science innovations. Throughout the day, visitors had the chance to explore new technologies up close, engage in…
MIMETAS, a leading organ-on-a-chip company, has announced the publication of a new peer-reviewed study that marks a major advance in cardiovascular disease research. The study, titled “Microfluidic artery-on-a-chip model with unidirectional gravity-driven flow for high-throughput applications”, presents a novel 3D…
Azafaros has raised €132 million in an oversubscribed Series B financing round. The funding will support the advancement of its lead clinical-stage asset, AZ-3102, into two Phase 3 trials for the treatment of rare lysosomal storage disorders: GM1 and GM2…
Two Leiden University research teams have been awarded grants through the HTSM programme, supporting advanced technology development with strong industry collaborations. DUAL IMPACT, led by Prof. Joost Batenburg (LIACS), aims to transform quality control in industries like food processing and…
Researchers at Leiden University Medical Center (LUMC) have developed PERISCOPE, an AI-driven tool designed to predict the risk of infections in postoperative patients. By analyzing nearly a decade of anonymized patient data, including vital signs and medical history, PERISCOPE assesses…
NecstGen has partnered with Paris-based biotech Astraveus to evaluate the Lakhesys™ Benchtop Cell Factory™, a microfluidic-based platform aiming to simplify and scale CAR-T production. The collaboration will test the system’s potential to reduce cost, footprint, and manual steps in a…
Leiden Bio Science Park welcomed a delegation from Trinity College Cambridge to explore shared innovation goals and strengthen ties between two leading science ecosystems. The visit featured knowledge exchange, campus tours, and conversations on how to grow talent, research, and…
What if you could design something that acts like an antibody, but cheaper, more stable, and made entirely with chemistry? Two LACDR researchers, Sebastian Pomplun and Matthias Barz, teamed up to do just that. By merging peptide synthesis with polymer…
Leiden Bio Science Park welcomed a high-level Shanghai delegation, led by Vice Mayor Liu Duo, marking a key step toward international collaboration in life sciences. The visit, initiated by Shanghai, showcased mutual interest in innovation and partnership.
The latest Life Sciences Café at Leiden Bio Science Park brought together students, startups, and seasoned professionals to share ideas and spark collaboration. Inspiring pitches from Sync Biosystems, Constellate Proteomics, and Kedi Bioscience made for a lively and engaging event.
Leiden Bio Science Park joined Innovation for Health 2025 in Rotterdam, spotlighting its thriving ecosystem of science and collaboration. Alongside partners, the Park showcased how innovation in health is advancing through shared knowledge and strong connections.